Low-dose Rifaximin in the Treatment of Covert Hepatic Encephalopathy

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
Several studies have been showed that rifaximin can improve cognitive functions, driving simulator performance and health-related quality of life in patients with minimal hepatic encephalopathy. The aim of this prospective randomized open controlled study was to evaluate the efficacy and safety of rifaximin at different doses for the treatment of covert hepatic encephalopathy.
Epistemonikos ID: 02fd4d0cbce71dc17e7995c0f72bb77a85959997
First added on: May 20, 2024